What is ASBP's dilution risk score?

ASBP currently has a DilutionScore of 68/100, indicating high dilution risk. DilutionWatch monitors ASBP SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for ASBP?

DilutionWatch tracks 25 SEC filing types for ASBP including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ASBP shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ASBP, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ASBP tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ASBP. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ASBP Stock Dilution Tracker: Score 68/100 (HIGH)

📊 Score Breakdown

📋 Offering Ability

90

💰 Cash Runway

0

📊 Float Risk

30

⚠️ Warrant Exposure

90

🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️

Warning

High probability of dilution event

52%

📜 Warrant Exercise 60%

• Massive warrant overhang: 3397% of shares outstanding

• Warrant risk score very high (90/100)

🔁 Convertible Conversion 60%

• Major convertible overhang: 144% potential dilution

• Convertible risk score very high (85/100)

💰 Capital Raise 20%

• Active shelf registration ($20M, 281% of market cap)

🔔 Track ASBP — Get forecast alerts →

💹 Market Data

Market Cap$7.11M

Shares Outstanding1.30M

Float1.20M

Cash$5.86M

Debt$1.50M

Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 12.5K shares

#1 UBS Group AG 6.4K shares

#2 Morgan Stanley 2.6K shares

#3 Geode Capital Management, LLC 1.4K shares

+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest76.0K

Days to Cover1.0

% of Float6.3%

FINRA data as of May 15, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025

xbrl XBRL WARRANT Dec 31, 2024

8-K/A 8K EVENT Apr 17, 2026

8-K 8K EVENT Apr 16, 2026

EFFECT EFFECT Apr 14, 2026

Full SEC filing analysis available with free account →

📰 Recent News

Aspire Biopharma (ASBP) Authorizes $5M Share Repurchase Program Insider Monkey · May 13

Aspire Biopharma’s Buzz Bomb partners with Blue Shark Beverages TipRanks · Feb 04

Aspire files patent application for clopidogrel sublingual powder formulation TipRanks · Jan 28

🔬 More Research for ASBP

📊 ASBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ASBP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

ASBP — Aspire Biopharma Holdings, Inc. Dilution Risk Tracker